1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Disease, Pulmonary

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Disease, Pulmonary in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (25.53)	18.7374
1990's	24 (51.06)	18.2507
2000's	9 (19.15)	29.6817
2010's	2 (4.26)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bieberbach, EWR; Fernandes, LC; Kryczyk, M; Michelotto, PV; Muehlmann, LA; Nishiyama, A; Zanatta, AL	1
Herndon, B; Molteni, A; Nzabi, M; Quinn, T; Wasson, N	1
Ishii, S; Pinho, V; Shimizu, T; Soares, AC; Souza, DG; Teixeira, MM	1
Geiser, T	1
Chen, DL; Hill, LL; Kozlowski, J; Schuster, DP	1
Bancalari, E; Huang, J; Rodriguez, MM; Smalling, WE; Suguihara, C	1
Cantu, J; Geyer, R; Jett, M; Jo, SC; Mani, S; Moss, OR; Peacock, AD; Saxton, AM; White, DC	1
Ahya, VN; Ardehali, A; Guenther, G; Keshavjee, S; Shargall, Y; Singhal, A	1
Willoughby, JB; Willoughby, WF	1
Wasserman, SI	1
Abu-Zidan, FM; Lennquist, S; Walther, S	1
Kaminskaia, GO	1
Bugelski, PJ; Esser, KM; Feuerstein, G; Griswold, DE; Hillegass, LM; Rabinovici, R; Vernick, J	1
Huang, YC; Kennedy, TP; Piantadosi, CA; Su, YF; Watkins, WD; Whorton, AR	1
Inui, K	1
Galloway, SW; Kingsnorth, AN	1
Chauvreau, C; Cornu, E; Denizot, Y; Feiss, P; Jauberteau, MO; Nathan, N	1
Bhagat, L; Bhatia, M; Frossard, JL; Hofbauer, B; Lee, HS; Saluja, AK; Steer, ML	1
Akizuki, E; Ishihara, K; Liang, J; Matsuda, T; Matsumura, F; Ogawa, M; Ohshiro, H; Okabe, K; Yamada, S; Yamaguchi, Y	1
Hugli, TE; Piccolo, MS; Piccolo, MT; Piccolo, NS; Sannomiya, P; Till, GO; Wang, Y; Ward, PA	1
Boichot, E; Braquet, P; Carre, C; Guinot, P; Lagente, V; Mencia-Huerta, JM	1
Cho, HG; Cho, O; Hybertson, BM; Lee, YM; Repine, AJ; Repine, JE; Terada, LS	1
Franke, U; Grote, M; Oppelt, P; Schaefers, HJ; Wahlers, T; Wittwer, T	1
Steer, ML	1
Banks-Schlegel, SP; Barnes, PJ; Henson, PM	1
Fassbender, M; Haller, H; Kaiser, D; Lode, H; Rau, M; Schaberg, T	1
Esser, KM; Feuerstein, G; Hillegas, LM; Rabinovici, R; Renz, JF; Sofronski, MD; Vernick, J	1
Chung, KF	1
Bottomicca, F; Camussi, G; Da Col, R; Libertucci, D; Scappaticci, E; Silvestro, L; Tetta, C	1
Bugelski, PJ; Esser, KM; Feuerstein, G; Griswold, DE; Hallenbeck, JM; Hillegass, LM; Lysko, PG; Rabinovici, R; Yue, TL	1
Barnes, PJ; Chung, KF; Evans, TW; Laurent, GJ; McAnulty, RJ; Rogers, DF	1
Anderson, BO; Banerjee, A; Bensard, DD; Harken, AH; Nelson, DW; Pitman, JM; Poggetti, RS; Shanley, PF; Whitman, GJ	1
Ishii, Y; Kitamura, S; Kobayashi, J	1
Crane, S; Johnstone, IB; Viel, L; Whiting, T	1
Johnson, KJ; Ward, PA; Warren, JS	1
Byrne, K; Carey, PD; Hirsch, JI; Sessler, CN; Sielaff, TD; Sugerman, HJ; Tatum, JL; Vasquez, A	1
Fleisher, LN; Joyce, PB; Olson, NC	1
Morris, HG	1
Eyre, P; Ogunbiyi, PO	1
Pacitti, N; Parratt, JR; Rodger, IW	1
Marone, G	1
Rylander, R	1
Deavers, SI; McManus, LM	1
Casals-Stenzel, J; Heuer, H	1
Alberton, M; Camussi, G; Coda, R; Macchiorlatti, E; Mariano, F; Montrucchio, G; Mularoni, E; Roffinello, C; Tetta, C	1
McManus, LM	1
Kurgan, J	1

Reviews

9 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Disease, Pulmonary

Article	Year
Immunologic mechanisms of parenchymal lung injury. Environmental health perspectives, 1984, Volume: 55 Topics: Animals; Arachidonic Acids; Arthus Reaction; Autoimmune Diseases; Biotransformation; Complement System Proteins; Disease Models, Animal; Free Radicals; Humans; Immune Complex Diseases; Lung Diseases; Lymphokines; Platelet Activating Factor	1984
The human lung mast cell. Environmental health perspectives, 1984, Volume: 55 Topics: Arachidonic Acid; Arachidonic Acids; Biotransformation; Bradykinin; Chemotaxis; Enzymes; Histamine; Humans; Lung; Lung Diseases; Mast Cells; Muscle, Smooth; Muscle, Smooth, Vascular; Oxidation-Reduction; Platelet Activating Factor; Serotonin	1984
[Platelet activating factor and its role in pulmonary pathology]. Problemy tuberkuleza, 1994, Issue:1 Topics: Humans; Lung Diseases; Platelet Activating Factor	1994
Mechanisms of glucocorticoid action in pulmonary disease. Chest, 1985, Volume: 88, Issue:2 Suppl Topics: Animals; Annexins; Arachidonic Acid; Arachidonic Acids; Asthma; Calcium-Binding Proteins; Chemotactic Factors; Glucocorticoids; Glycoproteins; Histamine Release; Humans; Inflammation; Lung; Lung Diseases; Platelet Activating Factor; Protein Biosynthesis; Pulmonary Gas Exchange; Receptors, Glucocorticoid; Status Asthmaticus	1985
Pharmacological studies of pulmonary anaphylaxis in vitro: a review. Agents and actions, 1985, Volume: 17, Issue:2 Topics: Anaphylaxis; Animals; Antigens; Cell Separation; Chemotactic Factors, Eosinophil; Disease Models, Animal; Dopamine; Histamine Release; Humans; In Vitro Techniques; Kinins; Lung; Lung Diseases; Mast Cells; Muscle Contraction; Muscle, Smooth, Vascular; Perfusion; Platelet Activating Factor; Prostaglandins; Receptors, Adrenergic, beta; Serotonin; SRS-A; Thromboxanes; Trachea	1985
Mediators of acute lung injury in endotoxaemia. Progress in clinical and biological research, 1989, Volume: 308 Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cats; Cyclooxygenase Inhibitors; Endotoxins; Escherichia coli; Lung; Lung Diseases; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Thromboxane-A Synthase; Thromboxanes	1989
The role of basophils and mast cells in the pathogenesis of pulmonary diseases. International archives of allergy and applied immunology, 1985, Volume: 76 Suppl 1 Topics: Anaphylaxis; Arachidonic Acid; Arachidonic Acids; Asthma; Basophils; Blood Platelets; Bronchial Provocation Tests; Calmodulin; Cyclic AMP; Deuterium; Deuterium Oxide; Histamine Release; Humans; Lung Diseases; Mast Cells; Peptide Hydrolases; Phospholipids; Platelet Activating Factor; Platelet Factor 4; Prostaglandin D2; Prostaglandins D; Receptors, IgE; Receptors, Immunologic; Serotonin; Water	1985
Platelet activating factor in pulmonary pathobiology. Clinics in chest medicine, 1989, Volume: 10, Issue:1 Topics: Animals; Blood Platelets; Humans; Lung; Lung Diseases; Platelet Activating Factor	1989
Pathobiology of platelet-activating factors. Pathology and immunopathology research, 1986, Volume: 5, Issue:2 Topics: Animals; Cardiovascular Diseases; Humans; Inflammation; Lung Diseases; Platelet Activating Factor	1986

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Disease, Pulmonary

Article	Year
Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2001, Volume: 20, Issue:3 Topics: Diterpenes; Double-Blind Method; Ginkgolides; Hemodynamics; Humans; Lactones; Lung Diseases; Lung Transplantation; Oxygen; Platelet Activating Factor; Prospective Studies; Reperfusion Injury	2001

Article

Year

Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2001, Volume: 20, Issue:3

Topics: Diterpenes; Double-Blind Method; Ginkgolides; Hemodynamics; Humans; Lactones; Lung Diseases; Lung Transplantation; Oxygen; Platelet Activating Factor; Prospective Studies; Reperfusion Injury

2001

Other Studies

37 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Disease, Pulmonary

Article	Year
Pulmonary inflammation due to exercise-induced pulmonary haemorrhage in Thoroughbred colts during race training. Veterinary journal (London, England : 1997), 2011, Volume: 190, Issue:2 Topics: Animals; Bronchoalveolar Lavage Fluid; Hemorrhage; Horse Diseases; Horses; Inflammation; Lung Diseases; Macrophages, Alveolar; Male; Oxidative Stress; Physical Conditioning, Animal; Platelet Activating Factor	2011
Urease and Helicobacter spp. antigens in pulmonary granuloma. Journal of comparative pathology, 2013, Volume: 148, Issue:2-3 Topics: Administration, Oral; Adult; Animals; Antigens, Bacterial; Disease Models, Animal; Female; Gastroesophageal Reflux; Granuloma; Helicobacter pylori; Humans; Interleukin-1beta; Lung; Lung Diseases; Lymphocytes; Male; Middle Aged; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sarcoidosis, Pulmonary; Urease	2013
Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. British journal of pharmacology, 2003, Volume: 139, Issue:4 Topics: Animals; Dihydropyridines; Disease Models, Animal; Imidazoles; Intestinal Diseases; Intestines; Lung Diseases; Male; Mesenteric Artery, Superior; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reperfusion Injury	2003
The role of neutrophils and neutrophil products in pulmonary hemodynamics of endotoxin in oleic acid-induced lung injury. Anesthesia and analgesia, 2004, Volume: 98, Issue:2 Topics: Animals; Endotoxins; Lung Diseases; Neutrophils; Oleic Acid; Phospholipases A; Platelet Activating Factor; Pulmonary Circulation; Rats	2004
Neutrophils and neutrophil products do not mediate pulmonary hemodynamic effects of endotoxin on oleic acid-induced lung injury. Anesthesia and analgesia, 2004, Volume: 98, Issue:2 Topics: Animals; Body Water; Cardiac Output; CD18 Antigens; Dogs; Endotoxins; Enzyme Inhibitors; Indoles; Lung; Lung Diseases; Magnetic Resonance Imaging; Neutrophils; Oleic Acid; Oxygen Consumption; Phospholipases A; Platelet Activating Factor; Pulmonary Circulation; Regional Blood Flow; Tomography, Emission-Computed	2004
Protective effect of pentoxifylline on volume-induced lung injury in newborn piglets. Biology of the neonate, 2004, Volume: 86, Issue:1 Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Biomechanical Phenomena; Inflammation; Lung; Lung Diseases; Lung Injury; Pentoxifylline; Peroxidase; Placebos; Platelet Activating Factor; Respiration, Artificial; Swine; Thromboxane B2; Tidal Volume	2004
Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology. Journal of microbiological methods, 2005, Volume: 62, Issue:3 Topics: Actinobacillus pleuropneumoniae; Animals; Breath Tests; Cell Line; Chromatography, High Pressure Liquid; Eicosanoids; Enterotoxins; Gas Chromatography-Mass Spectrometry; Humans; Lipids; Lipopolysaccharides; Lung Diseases; Phospholipids; Platelet Activating Factor; Rats; Respiratory Tract Infections; Spectrometry, Mass, Electrospray Ionization; Sus scrofa	2005
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Antithrombin III; Extracorporeal Membrane Oxygenation; Fluid Therapy; Free Radical Scavengers; Humans; Lung Diseases; Lung Transplantation; Matrix Metalloproteinases; Nitric Oxide; Platelet Activating Factor; Postoperative Care; Prostaglandins; Pulmonary Surfactants; Receptors, Complement; Reoperation; Reperfusion Injury; Respiration, Artificial	2005
Modulation of lung injury by platelet-activating factor antagonism in nonhypotensive porcine endotoxemia. Circulatory shock, 1994, Volume: 44, Issue:3 Topics: Animals; Escherichia coli; Female; Leucine; Lipopolysaccharides; Lung; Lung Diseases; Male; Platelet Activating Factor; Shock, Septic; Swine; Vascular Resistance	1994
Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:3 Topics: Animals; Antibodies, Monoclonal; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cricetinae; Indomethacin; Leukocyte Count; Leukocytes; Lipopolysaccharides; Lung; Lung Diseases; Male; Organ Size; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thromboxane A2; Time Factors; Tumor Necrosis Factor-alpha	1993
Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung. Journal of applied physiology (Bethesda, Md. : 1985), 1993, Volume: 74, Issue:1 Topics: Animals; Arachidonic Acids; Benzoquinones; Blood Pressure; Bronchoconstriction; Humans; Hypertension, Pulmonary; In Vitro Techniques; Indicators and Reagents; Indomethacin; Interferon Inducers; Interferon Type I; Lipoxygenase Inhibitors; Lung Diseases; Male; Microcirculation; Platelet Activating Factor; Poly I-C; Pulmonary Edema; Rabbits; Recombinant Proteins; Vascular Resistance	1993
[Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass]. [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai, 1993, Volume: 41, Issue:2 Topics: Animals; Cardiopulmonary Bypass; Dogs; Humans; Leukocyte Count; Lung Diseases; Platelet Activating Factor; Platelet Count; Reperfusion Injury	1993
Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist. Pancreas, 1996, Volume: 13, Issue:2 Topics: Acute Disease; Animals; Capillary Permeability; Coloring Agents; Evans Blue; Kidney; Leucine; Lung; Lung Diseases; Male; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar	1996
Cytokine and lipid mediator blood concentrations after coronary artery surgery. Anesthesia and analgesia, 1997, Volume: 85, Issue:6 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Complement System Proteins; Coronary Artery Bypass; Creatine Kinase; Cytokines; Extracorporeal Circulation; Female; Humans; Inflammation Mediators; Interleukins; Leukotrienes; Lipids; Lung Diseases; Male; Phospholipases A; Platelet Activating Factor; Postoperative Complications; Prospective Studies; Prostaglandins; Tumor Necrosis Factor-alpha	1997
Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology, 1998, Volume: 115, Issue:5 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acute Disease; Animals; Bile Ducts; Ceruletide; Disease Models, Animal; Gastrointestinal Agents; Ligation; Lung; Lung Diseases; Male; Opossums; Pancreas; Pancreatic Ducts; Pancreatitis; Phospholipases A; Platelet Activating Factor; Rats; Rats, Wistar; Recombinant Proteins	1998
Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. Pancreas, 1999, Volume: 18, Issue:4 Topics: Animals; Ceruletide; Chemokines, CXC; Chemotactic Factors; Growth Inhibitors; Growth Substances; Hemorrhage; Intercellular Signaling Peptides and Proteins; Isoquinolines; Kinetics; Lipopolysaccharides; Lung; Lung Diseases; Macrophages, Alveolar; Male; Pancreatitis; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rats; Rats, Wistar; RNA, Messenger; Sepsis; Tetrahydroisoquinolines	1999
Chemotactic mediator requirements in lung injury following skin burns in rats. Experimental and molecular pathology, 1999, Volume: 66, Issue:3 Topics: Animals; Antibodies, Blocking; Bronchoalveolar Lavage Fluid; Burns; Capillary Permeability; Chemokine CXCL2; Chemokines; Chemotactic Factors; Chemotaxis, Leukocyte; Complement C5a; Cytokines; Interleukin-1; Lung; Lung Diseases; Lung Injury; Male; Monokines; Neutrophils; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rabbits; Rats; Rats, Long-Evans; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Tumor Necrosis Factor-alpha	1999
Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1993, Volume: 23, Issue:12 Topics: Acetylcholine; Aerosols; Animals; Azepines; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Diterpenes; Eosinophilia; Ginkgo biloba; Ginkgolides; Guinea Pigs; Lactones; Leukotriene B4; Lung Diseases; Male; Molecular Structure; Ovalbumin; Plants, Medicinal; Platelet Activating Factor; Specific Pathogen-Free Organisms; Thienopyridines; Triazoles	1993
Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. American journal of physiology. Lung cellular and molecular physiology, 2000, Volume: 279, Issue:1 Topics: Animals; Azepines; Cell Adhesion; Indicators and Reagents; Interleukin-1; Intubation, Intratracheal; Leukocyte Count; Lung; Lung Diseases; Male; Neutrophils; Nitroblue Tetrazolium; Permeability; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Time Factors; Triazoles	2000
Relationship between pancreatitis and lung diseases. Respiration physiology, 2001, Volume: 128, Issue:1 Topics: Acute Disease; Animals; Complement C5a; Disease Models, Animal; Female; Humans; Intercellular Adhesion Molecule-1; Lung Diseases; Mice; Mice, Knockout; Neutrophils; Pancreatitis; Platelet Activating Factor; Rats; Receptors, CCR1; Receptors, Chemokine; Substance P	2001
NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. The American review of respiratory disease, 1992, Volume: 145, Issue:3 Topics: Asthma; Cardiovascular Diseases; Humans; Lung Diseases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled	1992
Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. The European respiratory journal, 1992, Volume: 5, Issue:4 Topics: Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Lung Diseases; Macrophages, Alveolar; Male; Middle Aged; Platelet Activating Factor; Smoking; Superoxides; Tetradecanoylphorbol Acetate	1992
Platelet activating factor mediates interleukin-2-induced lung injury in the rat. The Journal of clinical investigation, 1992, Volume: 89, Issue:5 Topics: Animals; Azepines; Blood Pressure; Interleukin-2; Leukocyte Count; Lung Diseases; Male; Peroxidase; Platelet Activating Factor; Platelet Count; Rats; Rats, Inbred Strains; Thromboxane B2; Triazoles; Tumor Necrosis Factor-alpha	1992
Platelet-activating factor in inflammation and pulmonary disorders. Clinical science (London, England : 1979), 1992, Volume: 83, Issue:2 Topics: Humans; Inflammation; Lung; Lung Diseases; Platelet Activating Factor	1992
Platelet-activating factor in bronchoalveolar lavage from patients with sarcoidosis. The American review of respiratory disease, 1992, Volume: 146, Issue:2 Topics: Adult; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Evaluation Studies as Topic; Female; Forced Expiratory Volume; Gallium Radioisotopes; Hospitals, University; Humans; Incidence; Italy; Lung Diseases; Lymphocytes; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; Platelet Activating Factor; Platelet Aggregation; Pulmonary Diffusing Capacity; Sarcoidosis; Sensitivity and Specificity; Severity of Illness Index; Vital Capacity	1992
Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circulation research, 1991, Volume: 69, Issue:1 Topics: Animals; Body Water; Cardiovascular Diseases; Drug Synergism; Endotoxins; Escherichia coli; Hemodynamics; Lipopolysaccharides; Lung; Lung Diseases; Male; Microscopy, Electron, Scanning; Organ Size; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thromboxane B2; Tumor Necrosis Factor-alpha	1991
Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion. Environmental health perspectives, 1990, Volume: 85 Topics: Administration, Inhalation; Administration, Oral; Albumins; Animals; Bleomycin; Diterpenes; Dose-Response Relationship, Drug; Extracellular Space; Ginkgolides; Lactones; Lung Diseases; Male; Organ Size; Platelet Activating Factor; Platelet Count; Rats; Rats, Inbred Lew	1990
Primed neutrophils injure rat lung through a platelet-activating factor-dependent mechanism. The Journal of surgical research, 1991, Volume: 50, Issue:5 Topics: Animals; Azepines; Lipopolysaccharides; Lung; Lung Diseases; Male; Neutrophils; Nitroblue Tetrazolium; Oligopeptides; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serum Albumin; Staining and Labeling; Triazoles	1991
[Roles of arachidonic acid cascade and related substances in respiratory diseases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Sep-10, Volume: 80, Issue:9 Topics: Animals; Arachidonic Acid; Asthma; Bronchi; Humans; Lung Diseases; Macrophages; Muscle Tonus; Platelet Activating Factor; Pulmonary Fibrosis; Respiratory Tract Diseases; Sarcoidosis; Smoking	1991
Hemostatic studies in racing standardbred horses with exercise-induced pulmonary hemorrhage. Hemostatic parameters at rest and after moderate exercise. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 1991, Volume: 55, Issue:2 Topics: Adenosine Diphosphate; Animals; Antithrombin III; Collagen; Factor VIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Horse Diseases; Horses; Lung Diseases; Partial Thromboplastin Time; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Thrombin Time; von Willebrand Factor	1991
PAF and immune complex-induced injury. Journal of lipid mediators, 1990, Volume: 2 Suppl Topics: Animals; Furans; Immune Complex Diseases; Lung Diseases; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Alveoli; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Vasculitis	1990
Platelet-activating factor in porcine Pseudomonas acute lung injury. The Journal of surgical research, 1991, Volume: 50, Issue:2 Topics: Analysis of Variance; Animals; Blood Pressure; Hemodynamics; Lung Diseases; Platelet Activating Factor; Pseudomonas Infections; Pulmonary Artery; Quinolines; Swine	1991
Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs. The American journal of physiology, 1990, Volume: 258, Issue:6 Pt 2 Topics: Animals; Body Water; Calcimycin; Capillary Permeability; Chromatography, High Pressure Liquid; Eicosanoids; Endotoxins; Escherichia coli; Heart; Leukotriene B4; Lung; Lung Diseases; Platelet Activating Factor; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Pulmonary Alveoli; Quinolines; Swine	1990
Role of endotoxin and glucan for the development of granulomatous disease in the lung. Sarcoidosis, 1989, Volume: 6 Suppl 1 Topics: Dust; Endotoxins; Glucans; Granuloma; Humans; Lung Diseases; Macrophages; Platelet Activating Factor; Tumor Necrosis Factor-alpha	1989
The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086. Progress in clinical and biological research, 1989, Volume: 308 Topics: Anaphylaxis; Animals; Antigens; Azepines; Disease Models, Animal; Endotoxins; Escherichia coli; Guinea Pigs; Lung Diseases; Ovalbumin; Platelet Activating Factor; Pyrilamine; Shock, Septic; Triazines; Triazoles	1989
The role of platelet-activating factor in experimental immune complex pathology. International journal of tissue reactions, 1985, Volume: 7, Issue:5 Topics: Animals; Antigen-Antibody Complex; Blood Vessels; Capillary Permeability; Chemical and Drug Induced Liver Injury; Complement C3; Female; Heart Diseases; Immune Complex Diseases; Kidney Diseases; Liver Diseases; Lung Diseases; Male; Platelet Activating Factor; Rabbits	1985
[Blood platelets and asthma and other lung diseases]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1987, Jul-20, Volume: 42, Issue:29 Topics: Asthma; Bronchial Spasm; Humans; Lung Diseases; Platelet Activating Factor	1987